FDA Approved: TRESIBA — Original Application (Novo Nordisk)

View source ↗

Summary

FDA approved the original Biologics License Application for Tresiba (insulin degludec) from Novo Nordisk, establishing a long-acting insulin for glycemic contro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus
• Type 2 Diabetes Mellitus

Drugs mentioned

• Tresiba (insulin degludec)

Snippet

ORIG AP for TRESIBA (INSULIN DEGLUDEC)